Excelsior Medical Co., Ltd. · TWSE:4104
Excelsior Medical — Q2 2018 Earnings Presentation
33 slides from Excelsior Medical's earnings presentation, 2018
Slide 1: Excelsior Medical Co., Ltd. 2018Q2 Investor Conference
Excelsior Medical Co., Ltd. 2018Q2 Investor Conference
Slide 2: Disclaimer
Disclaimer This presentation is prepared according to the reviewed financial statements by CPA and the financial figures hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ materially f
Slide 3: Table of Contents
Table of Contents 1.公司概況(Corporate Overview) P.4 2.市場概況(Market Overview) P.8 3.營運概況(Business Overview) P.11 4.財務概況(Financial Overview) P.14 5.轉投資概況(Investment Overview) P.17 6.2018策略及展望(2018 Strategies and Outlook) P.23 7.補充資料(Appendix) P.26 3
Slide 4: Corporate Overview
Corporate Overview Chairman Group President Tony Fu “Dedication, Discipline, Innovation, Proactive” are the core values of Excelsior . “Human Healthcare” is the basis of medical service industry. Therefore, “Dedication” to our service target is what matters the most. We focus on public healthcare, u
Slide 5: The Most Valuable Total Healthcare Solution Provider among Asia
The Most Valuable Total Healthcare Solution Provider among Asia with Exceptional Investment and Operating Teams！ Excelsior Medical Co.,Ltd. was founded in 1988，Excelsior started with the distribution of hemodialysis equipments and supplies . Gradually transformed into medical services integration ch
Slide 6: Revenue structure
Revenue structure Excelsior yearly consolidated sales is more than NT $ 6 billion, the primary revenue comes from Excelsior(Hemodialysis), Dynamic(Medical Aesthetic), Arich (Pharmaceutical Logistics) and others. According to the company’s function ,the business type can be characterized as trading b
Slide 7: The Business Types
The Business Types Hemodialysis Medical Aesthetic Trading Business Medical Equipment Medical Consumables Home Appliance Product Planning Sales Information Analysis Promotion Hemodialysis channel Medical Information System Market Creative Medical Aesthetic channel Pharmaceutical Distribution Manageme
Slide 8: Market Overview
Market Overview Excelsior(Hemodialysis) Taiwan benefited from the implementation of the national health insurance system in 1995 and the hemodialysis technology and quality gradually mature, the patient's survival rate has gradually increased. According to National Kidney Foundation R.O.C statistics
Slide 9: Dynamic (Medical Aesthetic)
Dynamic(Medical Aesthetic) According to the Asian-Pacific Market Study issued by Medical Insight, Inc. in Nov. 2016, total Asian sales of all aesthetic products and equipment reached USD $1.35 billion in 2016 and are expected to increase by 13.7% per year through 2021. Furthermore, medical aesthetic
Slide 10: Arich (Pharmaceutical Logistics)
Arich (Pharmaceutical Logistics) Pharmaceuticals cost approximately 1/4 of National Health Insurance expenditures. In Taiwan, although demand for medication is growing, but the prices approved/reimbursed by NHI are declining. Consequently the multinational pharmaceutical companies keep on outsourcin
Slide 11: Business Overview: Excelsior (Hemodialysis)
Business Overview Excelsior(Hemodialysis) Excelsior Operating income was NT $ 165,028 Units: NTD in thousands (NTD in thousands) in 2016 and it was 3,404,487 3,561,288 NT $ 267,803 (NTD in thousands)in 2017 ， 7% 7% the growth rate was+62.3%。 Operating 32% income in the first half of 2018 was NT $ 34
Slide 12: Dynamic (Medical Aesthetic)
Dynamic(Medical Aesthetic) Units: NTD in thousands Dynamic operating income was $ 194,682 (NTD in thousands) in 2016, and $ 194,093 (NTD in thousands) in 2017. Operating Income for 18% 16% the first half of 2018 was $ 74,131 (NTD in thousands). Compared to the corresponding 53% 54% period of 2017, i
Slide 13: Arich (pharmaceutical logistics)
Arich (pharmaceutical logistics) Units: NTD in thousands Arich Operating income was NT$ 47,982 22% thousand dollars in 2016 but NT$ 2,739 20% thousand dollars in 2017, because it was a transitional period of customers and revenues composition. In the first half of 2018, it grows up tp NT$ 23,866 tho
Slide 14: Financial Overview
Financial Overview Consolidated sales Consolidated gross profit Units: NTD in thousands Units: NTD in thousands Consolidated operating income Units: NTD in thousands 14
Slide 15: Units: NTD in thousands Units: NTD in thousands
Units: NTD in thousands Units: NTD in thousands 15
Slide 16: Units: NTD in thousands Units : NTD in Dollars
Units: NTD in thousands Units : NTD in Dollars 16
Slide 17: Investment Overview: Hemodialysis channel
Investment Overview Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd 【 Hemodialysis channel Introduction 】 Excelsior entered into a joint venture with Fresenius which is the world's largest manufacturer of dialysis products, and establishes long-term cooperative
Slide 18: Hemodialysis channel – Excelsior Renal Service
Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd Units : except ERS channels， NTD in thousands 18
Slide 19: Hemodialysis channels
Total % Area ERS channels channels Taipei：20 keelong：2 North 239 31 13.0% Central 191 47 24.6% South 182 20 11.0% other 37 1 2.7% Total 649 99 15.3% Taoyuan：7 Hsinchu：2 Miaoli：3 Taichung：26 Changhua：7 Yilan ：1 Yunlin：2 Nantou：5 Chiayi：4 Tainan：9 pingtung：4 Kaohsiung：7 Hemodialysis channels 19
Slide 20: Long-Term Care Channels – Asia Best Healthcare
Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Xi-zhi Nursing Home 內部配置 【 Long-Term Care Channels Introduction 】 Excelsior combines the experiences and advantages in medical industry, with innovative concepts to build higher service standards of long-term care channels. We provide Long Term
Slide 21: Long-Term Care Channels – Asia Best Healthcare
Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Units:except ABH Beds， NTD in thousands 招大廳 21
Slide 22: Long-term care channels
Hospital/long-term care Hospital Beds 525 Long-term care channels Long-term care 2,538 Total 3,063 Xi keelong：114 beds -zhi Taoyuan : 174 beds Taipei：165 beds Ping -zhen New Taipei City： 1,241 beds Taichung：591 beds Tai -chung Changhua:200 beds Yunlin ：100 beds Kaoh -siung Nantou ：294 beds Kaohsiung
Slide 23: 2018 Strategies and Outlook
2018 Strategies and Outlook Excelsior(Hemodialysis) Long-Term Planning Mid-Term Planning Excelsior develops from Taiwan to Asia , and follows government’s direction “The 1.Integrating upstream and New Southbound Policy ”, we downstream medical resources , will proceed to focus on increasing business
Slide 24: Dynamic (Medical Aesthetic)
Dynamic(Medical Aesthetic) Long-Term Planning Being a product leader in Mid-Term Planning the medical cosmetology Viveve market Belviq As a market leader, All-round one-stop beauty continue to lead Leading therapy service the market for beauty Short-Term Plan Medytox_Neuronox Ulthera P
Slide 25: Arich (pharmaceutical logistics)
Arich (pharmaceutical logistics) Long-Term Planning 1.Sales Revenue Mid-Term Planning A.To seek strategic partners and to expand the variety of our 1.Sales Revenue products. A.Medication：To B.To develop business about increase our product items. medication investment, clinical trial, B.Health Supple
Slide 26: Appendix
Appendix Units: In thousands NTD 2016.12.31 2017.12.31 2018.06.30 Assets Current Assets Cash and Cash Equivalents 3,845,941 3,444,328 3,047,919 Receivables 2,163,308 2,199,672 1,995,128 Other Receivables 4,783,800 3,562,727 3,925,091 Inventories 1,025,183 1,121,982 1,109,526 Other Current Assets 619
Slide 27: Liabilities
Units: In thousands NTD 2016.12.31 2017.12.31 2018.06.30 Liabilities Current Liabilities Short-Term Loan 905,000 1,160,000 1,240,000 Payables 1,230,959 1,029,336 977,258 Other Payables 4,762,518 3,262,492 3,407,412 Other Liabilities 782,420 954,248 461,502 Total Current Liabilities 7,680,897 6,406,0
Slide 28: Statement of comprehensive income
Statement of comprehensive income Units: In thousands NTD 2016 2017 2018.06 Operating Revenue 6,205,758 6,095,337 3,118,205 Operating Costs 5,009,038 4,889,039 2,503,141 Gross Profit 1,196,720 1,206,298 615,064 Gross Margin 19.28% 19.79% 19.72% Operating Expense 817,224 753,736 379,522 Operating Inc
Slide 29: Cash flows from operating activities
Units: In thousands NTD 2016 2017 2018.06 Profit before income tax 578,614 554,237 331,307 Adjustments items (76,876) (60,595) (40,952) Cash flows from operating Activities Receivable (increase) decrease (260,784) (106,519) 142,105 Other Receivable (increase) (929,242) 1,244,175 (302,462) decrease I
Slide 30: Cash flows from investing activities
Units: In thousands NTD 2016 2017 2018.06 Cash flows from investing activities Purchase of financial assets at - - (658,160) amortized cost Proceeds from disposal of - - 834,343 financial assets at amortized cost Purchase of debt investments with (1,088,505) (715,670) - no active market Proceeds fro
Slide 31: Cash flows from financing activities
Units: In thousands NTD 2016 2017 2018.06 Cash flows from financing Activities Increase in short-term borrowings 12,000 255,000 80,000 Repayments of bonds - - (300,000) Repayments of long-term borrowings (5,707) (9,920) - Increase in long-term payables to a related party 259,561 - - Dividends paid t
Slide 32: Growing up with Long-term partners
Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China
Slide 33: Growing up with Long-term partners
Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China